Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

FDG-PET and 3-phase bone scintigraphy to differentiate diffuse sclerosing osteomyelitis from other refractory chronic osteomyelitis of jaws

Yoshimasa Kitagawa, Takuya Asaka, Hironobu Hata, Jun Sato, Yutaka Yamazaki, Shozo Okamoto, Naoya Hattori, Tohru Shiga and Nagara Tamaki
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 252;
Yoshimasa Kitagawa
1Oral Diagnosis and Medicine, Hokkaido Univ., Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takuya Asaka
1Oral Diagnosis and Medicine, Hokkaido Univ., Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hironobu Hata
1Oral Diagnosis and Medicine, Hokkaido Univ., Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Sato
1Oral Diagnosis and Medicine, Hokkaido Univ., Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yutaka Yamazaki
1Oral Diagnosis and Medicine, Hokkaido Univ., Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shozo Okamoto
2Nuclear Medicine, Hokkaido Univ., Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoya Hattori
2Nuclear Medicine, Hokkaido Univ., Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tohru Shiga
2Nuclear Medicine, Hokkaido Univ., Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nagara Tamaki
2Nuclear Medicine, Hokkaido Univ., Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

252

Objectives Diffuse sclerosing osteomyelitis (DSO) of the mandible is characterized by recurrent pain, swelling and trismus, mimicing other refractory osteomyelitis. Differentiation of DSO is very difficult by conventional imaging modalities. Inadequate diagnosis may often lead to intractable and prolonged conditions. The aim of this prospective study was to appraise the value of FDG-PET/CT and 3-phase bone scintigraphy in differentiation of DSO from other osteomyelitis of jaws.

Methods A total of 53 patients (Age: 35-90; M/F: 28/25) with osteomyelitis of jaws were enrolled in this study; Imaging characteristics of 10 DSO were compared with those of 13 bisphosphonate-related osteonecrosis of jaws (BRONJ), 14 ORN, and 16 odontogenic infection. Each patient underwent FDG-PET and 3-phase bone scintigraphy. Each image of 3-phase bone scan (perfusion, pool, static) was analyzed using 4 point grading system (G0-G3).

Results The mean SUVmax of DSO, BRONJ, ORN, and odontogenic was 1.99±0.56, 4.34±0.92, 3.34±1.95, and 2.33±1.20, respectively. DSO (PET and perfusion: 1.99±0.56 and 0.2±0.42) and odontogenic (2.33±1.20 and 0.25±0.44) showed significantly lower accumulation in PET and perfusion images than BRONJ (4.34±0.92 and 1.6±0.87). Static images in DSO (2.8±0.42) and BRONJ (2.8±0.38) showed significantly higher uptake than odontogenic (1.8±0.87), reflecting higher remodeling activities. DSO with nonbacterial inflammation demonstrated relatively low and focal FDG accumulation, in striking contrast with characteristically increased uptake in pool images. In all patients, accurate diagnoses and appropriate treatment strategies were made.

Conclusions FDG-PET combined with 3-phase bone scintigraphy is clinically useful for the differentiation of DSO from other osteomyelitis of Jaws, because these combinations facilitate differentiation of inflammation and infection from bone remodeling, which is sometimes difficult to be characterized by other images.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FDG-PET and 3-phase bone scintigraphy to differentiate diffuse sclerosing osteomyelitis from other refractory chronic osteomyelitis of jaws
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
FDG-PET and 3-phase bone scintigraphy to differentiate diffuse sclerosing osteomyelitis from other refractory chronic osteomyelitis of jaws
Yoshimasa Kitagawa, Takuya Asaka, Hironobu Hata, Jun Sato, Yutaka Yamazaki, Shozo Okamoto, Naoya Hattori, Tohru Shiga, Nagara Tamaki
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 252;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
FDG-PET and 3-phase bone scintigraphy to differentiate diffuse sclerosing osteomyelitis from other refractory chronic osteomyelitis of jaws
Yoshimasa Kitagawa, Takuya Asaka, Hironobu Hata, Jun Sato, Yutaka Yamazaki, Shozo Okamoto, Naoya Hattori, Tohru Shiga, Nagara Tamaki
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 252;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • COMMON PEDIATRIC NUCLEAR MEDICINE IMAGING STUDIES: A COMPREHENSIVE REVIEW
  • COVID-19 and Nuclear Medicine: what we know so far…
  • Utility of Depth Correction Calculator for Split Renal Function Studies utilizing prior CT or MRI
Show more General Clinical Specialties

Musculoskeletal I: PET & Experimental Imaging

  • Successful imaging of osteoarthritis with 99mTc radiolabeled chondroitin sulfate (CS) in dogs
  • Efficacy of 18F-FDG PET/CT guided botulinum toxin therapy in idiopathic cervical dystonia
Show more Musculoskeletal I: PET & Experimental Imaging

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire